CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts

Journal of Bone and Mineral Research

Volumn 26, Issue 2, 2011, Pages 308-316

  Ofek, Orr ^a   Attar Namdar, Malka ^a   Kram, Vardit ^a   Dvir Ginzberg, Mona ^a   Mechoulam, Raphael ^a   Zimmer, Andreas ^b   Frenkel, Baruch ^c   Shohami, Esther ^a   Bab, Itai ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

CB2 CANNABINOID RECEPTOR; CREB; CYCLIN D1; MAP KINASE; MAPKAPK2; MITOGENIC SIGNALING; OSTEOBLAST

Indexed keywords

CANNABINOID 2 RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; PROTEIN KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALVARIA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; MITOGENESIS; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BUTADIENES; CYCLIN D1; FLAVONOIDS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGENS; NITRILES; OSTEOBLASTS; RECEPTOR, CANNABINOID, CB2; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 79251500011     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.228     Document Type: Article

References (49)

1. Di Marzo V., Targeting the endocannabinoid system: to enhance or reduce ? Nat Rev Drug Disc. 2008; 7: 438-455.
2. Mackie K., Cannabinoid receptors: where they are and what they do. J Neuroendocrinol. 2008; 20: 10-14.
3. Ofek O, Karsak M, Leclerc N, et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA. 2006; 103: 696-701.
4. Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A., Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol. 2008; 20: (suppl 1): 69-74.
5. Idris AI, Sophocleous A, Landao-Bassonga E, vant Hof RJ, Ralston SH., Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology. 2008; 149: 5619-5626.
6. Gutkind JS., Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene. 1998; 17: 1331-1342.
7. Hipskind RA, Bilbe G., MAP kinase signaling cascades and gene expression in osteoblasts. Front Biosci. 1998; 3: d804-16.
8. Waskiewicz AJ, Cooper JA., Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol. 1995; 7: 798-805.
9. Robinson MJ, Cobb MH., Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997; 9: 180-186.
10. Huang Z, Cheng SL, Slatopolsky E., Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation. J Biol Chem. 2001; 276: 21351-21358.
11. Franceschi RT, Xiao G., Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem. 2003; 88: 446-454.
12. Miguel SM, Namdar-Attar M, Noh T, Frenkel B, Bab I., ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells. J Biol Chem. 2005; 280: 37495-3502.
13. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J., Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res. 2003; 18: 2060-2068.
14. Swarthout JT, Tyson DR, Jefcoat SC Jr, Partridge NC., Induction of transcriptional activity of the cyclic adenosine monophosphate response element binding protein by parathyroid hormone and epidermal growth factor in osteoblastic cells. J Bone Miner Res. 2002; 17: 1401-1407.
15. Howlett AC., Cannabinoid receptor signaling. Handb Exp Pharmacol. 2005; 53-79.
16. Rajesh M, Mukhopadhyay P, Hasko G, Huffman JW, Mackie K, Pacher P., CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol. 2008; 153: 347-357.
17. Murikinati S, Juttler E, Keinert T, et al. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J. 2009; 24: 788-798.
18. Buckley NE, McCoy KL, Mezey E, et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol. 2000; 396: 141-149.
19. Bajayo A, Goshen I, Feldman S, et al. Central IL-1 receptor signaling regulates bone growth and mass. Proc Natl Acad Sci U S A. 2005; 102: 12956-12961.
20. Gabarin N, Gavish H, Muhlrad A, et al. Mitogenic G(i) protein-MAP kinase signaling cascade in MC3T3-E1 osteogenic cells: activation by C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)] and attenuation of activation by cAMP. J Cell Biochem. 2001; 81: 594-603.
21. Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002; 157: 303-314.
22. Hanus L, Breuer A, Tchilibon S, et al. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci U S A. 1999; 96: 14228-14233.
23. Malan TP Jr, Ibrahim MM, Deng H, et al. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain. 2001; 93: 239-245.
24. Felder CC, Joyce KE, Briley EM, et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol. 1995; 48: 443-450.
25. Cuenda A, Rouse J, Doza YN, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995; 364: 229-233.
26. Fukunaga R, Hunter T., MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 1997; 16: 1921-1933.
27. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ., FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 1996; 15: 4629-4642.
28. Yadav VK, Ryu JH, Suda N, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 2008; 135: 825-837.
29. Bayewitch M, Rhee MH, Avidor-Reiss T, Breuer A, Mechoulam R, Vogel Z., (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J Biol Chem. 1996; 271: 9902-9905.
30. Idris AI, vant Hof RJ, Greig IR, et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med. 2005; 11: 774-779.
31. Tam J, Ofek O, Fride E, et al. Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol Pharmacol. 2006; 70: 786-792.
32. Chen C, Koh AJ, Datta NS, et al. Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem. 2004; 279: 29121-29129.
33. Bianchi EN, Ferrari SL., Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts. Bone. 2009; 45: 716-725.
34. Ferguson SS., Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol Sci. 2007; 28: 173-179.
35. Katanaev VL, Chornomorets M., Kinetic diversity in G-protein-coupled receptor signalling. Biochem J. 2007; 401: 485-495.
36. Yu X, Hsieh SC, Bao W, Graves DT., Temporal expression of PDGF receptors and PDGF regulatory effects on osteoblastic cells in mineralizing cultures. Am J Physiol. 1997; 272: C1709-16.
37. Swarthout JT, Doggett TA, Lemker JL, Partridge NC., Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J Biol Chem. 2001; 276: 7586-7592.
38. ter Haar, E., Activating MAP KAP kinase 2. Structure. 2003; 11: 611-612.
39. Marshall CJ., Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995; 80: 179-185.
40. Jessop HL, Sjoberg M, Cheng MZ, Zaman G, Wheeler-Jones CP, Lanyon LE., Mechanical strain and estrogen activate estrogen receptor alpha in bone cells. J Bone Miner Res. 2001; 16: 1045-1055.
41. Ghayor C, Rey A, Caverzasio J., Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor beta in mouse osteoblastic cells. Bone. 2005; 36: 93-100.
42. Clerk A, Michael A, Sugden PH., Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy ? J Cell Biol. 1998; 142: 523-535.
43. Shimoaka T, Ogasawara T, Yonamine A, et al. Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J Biol Chem. 2002; 277: 7493-7500.
44. Mehrotra M, Krane SM, Walters K, Pilbeam C., Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem. 2004; 93: 741-752.
45. Rouse J, Cohen P, Trigon S, et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994; 78: 1027-1037.
46. Ben-Levy R, Leighton IA, Doza YN, et al. Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. EMBO J. 1995; 14: 5920-5930.
47. Datta NS, Pettway GJ, Chen C, Koh AJ, McCauley LK., Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells. J Bone Miner Res. 2007; 22: 951-964.
48. Herber B, Truss M, Beato M, Müller R., Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 1994; 9: 1295-1304.
49. Chen C, Koh AJ, Datta NS, et al. Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem. 2004; 279: 29121-29129.